For diabetics with atrial fibrillation, GLP-1 drugs may beat SGLT-2 drugs on survival. Discover what a new study reveals.

People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline.

A new meta-analysis led by researchers from the Fatty Acid Research Institute (FARI) provides the clearest picture to date of ...

An estimated 10 million Americans have atrial fibrillation (AFib), according to the National Institutes of Health's National ...

Atrial Fibrillation Symptoms: Experts say that with increasing age, the increasing burden of obesity, diabetes, and ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

During atrial fibrillation, the atrioventricular node is bombarded with electrical impulses, which typically result in rapid ventricular rates. The rate at which signals are transmitted to the ...

Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...

It's the season for parties and celebrating the end of another year, but having a few too many drinks can leave you feeling less than merry. Perhaps it's a thumping headache, a feeling of "jitteriness ...

This article presents an example of how clinical trial data may be complemented by real-world evidence by reviewing pivotal clinical trial data for one direct oral anticoagulant (DOAC), along with an ...